Compliance Management Products & Services

1. GLP-1 Receptor Agonist Solutions 9/2/2025

   The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.

2. Solutions For Injectables And Parenteral Formulations 8/27/2025

   Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.

3. Setting New Standards In Active Air Monitoring 8/25/2025

   By combining proven performance, refined data handling and smart features, the MAS-100 Sirius® air sampler makes active air monitoring in high-grade cleanrooms more reliable and convenient than ever before.

4. The Key To Better Visual Inspection Practices 8/25/2025

   Bridge regulatory gaps in visual inspection and improve product quality by managing defects throughout the product lifecycle. Get a better understanding of how a centralized data repository can help.

5. Make Traceability A Seamless Part Of Your Operations 8/19/2025

   Take control of your production by tracking every part, assembly, and batch with precision.

6. Minimize Risk With Interactive Logbooks 8/19/2025

   Guide operators through dynamic workflows from equipment startup to maintenance.

7. Validation Doesn't Need To Bleed Time Or Money 7/23/2025

   Reduce manual validation efforts, cut costs by up to 30%, get new products out the door faster, and enable seamless regulatory inspections.

8. Composable MES For Pharma 6/30/2025

   The Composable MES for Pharmaceuticals provides a starting point for you to implement a tailored, connected production system with end-to-end traceability and right-the-first-time electronic batch records (eBR).

9. Manufacture High-Quality Products With Streamlined Compliance 6/26/2025

   Manufacture high-quality products with streamlined compliance.

10. Combat Nitrosamine Challenges With Comprehensive Analytical Solutions 6/18/2025

    As consumer safety becomes increasingly vital, the analysis of nitrosamine impurities in pharmaceuticals is critical. Classified as probable human carcinogens, nitrosamines pose significant health risks, prompting regulatory bodies like the U.S. Food and Drug Administration (FDA), Health Cananda and the European Food Safety Authority (EFSA) to implement strict guidelines.